85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details


臨床試験数 : 598 薬物数 : 435 - (DrugBank : 116) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 209

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2010-023828-24-GB
(EUCTR)
09/06/201127/04/2011The effect of Thalidomide on sputum biomarkers in IPF cough. - The effect of Thalidomide on sputum biomarkers in IPF coughThe effect of Thalidomide on sputum biomarkers in IPF cough. - The effect of Thalidomide on sputum biomarkers in IPF cough Cough in Idiopathic Pulmonary fibrosis.Trade Name: Thalidomide Pharmion
Product Name: Thalidomide Pharmion
Trade Name: PREDNISOLONE
Product Name: prednisolone
University of NottinghamNULLNot RecruitingFemale: yes
Male: yes
United Kingdom
2NCT00600028
(ClinicalTrials.gov)
December 200711/1/2008Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With ThalidomideTreatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With ThalidomideIdiopathic Pulmonary Fibrosis;CoughDrug: Thalidomide;Drug: PlaceboJohns Hopkins UniversityNULLCompleted50 YearsN/AAll25Phase 3United States
3NCT00162760
(ClinicalTrials.gov)
October 20038/9/2005Treatment of Idiopathic Pulmonary Fibrosis With ThalidomideTreatment of Idiopathic Pulmonary Fibrosis With ThalidomideIdiopathic Pulmonary Fibrosis (IPF)Drug: ThalidomideJohns Hopkins UniversityCelgene CorporationCompleted50 Years80 YearsBoth19Phase 2United States